Abstract:Objective: We aimed to explore the diagnostic and therapeutic efficacy of cystoscopy with hydrodistension and random biopsies for clinically suspected interstitial cystitis/bladder pain syndrome (IC/BPS). Study design: We reviewed the data of fifty-five clinically suspected IC/BPS patients underwent cystoscopy with hydrodistension and random biopsies. Global Response Assessment was used to evaluate the efficacy. Disease severity was assessed by thorough history, physical examination, 3-day frequency volume chart, visual analog scale of pain, Interstitial Cystitis Symptom Index (ICSI) and clinical phenotype system (UPOINT). Results: According to the pathologic outcomes from random biopsies, three out of the 55 clinically suspected IC/BPS were diagnosed as bladder carcinoma. Among the 52 IC/BPS patients, thirty-six patients (69.2%) had initial chief complaints of urinary frequency and urgency. Under cystoscopy, twenty-nine patients and 23 patients were classified as Hunner ulcer type and diffuse global mucosal bleeding (grade III glomerulation). The median functional bladder capacity of the 52 IC/BPS patients was 100 ml. Hydrodistension was effective in 28 patients (53.8%) at postoperative 3 months, which decreased to 25% at post-hydrodistension 6 months and to 13.5% at 12 months. For the 28 hydrodistensioneffective patients, the remission degrees of daytime frequency, nocturia, VAS bladder pain and ICSI score were 50.3%, 49.4%, 68.1% and 48%, which were significantly higher than the 16.9% (daytime frequency, P < 0.001), 20.5% (nocturia, P = 0.021), 7.4% (VAS pain score, P < 0.001) and 6.1% (ICSI, P < 0.001) in the hydrodistension-negative group. According to the UPOINT system, the hydrodistension-effective cases had significantly higher rates of symptom remission in U (P = 0.002), P (P = 0.026), O (P < 0.001), and T (P < 0.001) domains than the corresponding negative cases. In effective group, the O domain had the most remission rate (26 out of 28, 92.9%, P < 0.001), followed by the U domain (12 out of 28, 42.9%, P < 0.001) and T domain (12 out of 28, 42.9%, P < 0.001). Conclusion: Histopathological analysis from random biopsies could distinguish bladder carcinoma from clinically suspected IC/BPS. Hydrodistension is more likely to be effective when chronic pelvic pain is obviously alleviated. The efficacy of hydrodistension could act in a certain period of time. (c) 2021 Published by Elsevier B.V.

Risk Factors for Interstitial Cystitis/painful Bladder Syndrome in Patients with Lower Urinary Tract Symptoms: a Chinese Multi-Center Study

Risk factors for interstitial cystitis/painful bladder syndrome in patients with lower urinary tract symptoms presenting for urologic care

Sex Differences in Risk Factors for Interstitial Cystitis/painful Bladder Syndrome in Patients with Lower Urinary Tract Symptoms in China

Potential Urine and Serum Biomarkers in Patients with Bladder Pain Syndrome/Interstitial Cystitis

Urinary Biomarkers in Interstitial Cystitis/Bladder Pain Syndrome and Its Impact on Therapeutic Outcome

Increased risks of healthcare-seeking behaviors of anxiety, depression and insomnia among patients with bladder pain syndrome/interstitial cystitis: a nationwide population-based study

The Characteristics and Risk Factors of Healthcare-Seeking Men with Lower Urinary Tract Symptoms in China: Initial Report from the POInT Group

The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome

Association of diet and lifestyle with chronic prostatitis/chronic pelvic pain syndrome and pain severity: a case-control study

Treatment approaches for painful bladder syndrome/interstitial cystitis

Multi‐omics analyses uncover metabolic signatures and gene expression profiles of interstitial cystitis/bladder pain syndrome

Molecular pathogenesis of interstitial cystitis/bladder pain syndrome based on gene expression

Neutrophil-to-lymphocyte Ratio As a Promising Non-Invasive Biomarker for Symptom Assessment and Diagnosis of Interstitial Cystitis/bladder Pain Syndrome.

Relationship among Diet Habit and Lower Urinary Tract Symptoms and Sexual Function in Outpatient-Based Males with LUTS/BPH: a Multiregional and Cross-Sectional Study in China

Increased expression of TNF ligand-related molecule 1A and death receptor 3 in bladder tissues of patients with painful bladder syndrome/interstitial cystitis.

The Diagnostic and Therapeutic Efficacy of Cystoscopy with Hydrodistension and Random Biopsies in Clinically Suspected Interstitial Cystitis/bladder Pain Syndrome.

412 Symptoms, Sexual Dysfunction and Psychological Burden in Chinese Men with Chronic Prostatitis/ Chronic Pelvic Pain Syndrome

The microbiota in patients with interstitial cystitis/bladder pain syndrome: a systematic review

Chinese Urologists' Practice Patterns of Diagnosing and Treating Chronic Pelvic Pain Syndrome: a Questionnaire Survey.

Dietary Influence on Bladder Pain Syndrome: A Systematic Review

Promising Experimental Treatment in Animal Models and Human Studies of Interstitial Cystitis/Bladder Pain Syndrome